Pat Arensdorf

Life Science Angels (LSA) is the premier angel investing organization in the US, focused on investing exclusively in the life sciences. Since 2005, LSA has invested in 100+ companies in medical technology and biotechnology investment opportunities.

Entrepreneurs First invests in exceptional individuals to build startups from scratch. We bring together talented outliers to develop their most ambitious ideas and raise money from the world’s best investors. Since pioneering Talent Investing in 2015, we’ve learned to recognize individuals with extraordinary futures before anyone else, embedding them in a community of ambitious peers and giving them the tools they need to succeed, fast. We back them before they have a company, a team, even before they have an idea, based purely on talent. EF’s portfolio is now collectively valued at over $16B, and includes companies such as Aztec, Cleo, Magdrive, Neptune, Omnea, Opply, PolyAI, Tractable, and many more. EF is backed by some of the worlds leading founders and investors, including Founders Fund, Greylock, John Collison (founder – Stripe), Patrick Collison (founder – Stripe), Reid Hoffman (founder – LinkedIn), Eric Schmidt (former CEO - Google), Demis Hassabis (founder – Google DeepMind ), Taavet Hinrikus (founder – Wise), Matt Mullenweg (founder – WordPress), Charlie Songhurst (Board member – Meta), Christa Davies (Board member – Stripe), Lachy Groom (founder – Physical Intelligence), Aidan Gomez (founder – Cohere), Mati Staniszewski (founder – ElevenLabs), Danny Rimer (Partner - Index Ventures), Matt Cohler (former General Partner - Benchmark). We exist to make great companies happen that otherwise wouldn’t. For more information about Entrepreneurs First, visit www.joinef.com Were hiring! Join our global team and experience firsthand the workings of a globally unique talent investor working with cutting edge entrepreneurs on world changing technologies: https://www.joinef.com/about/careers

Exai Bio is a next-generation liquid biopsy company. Our mission is to enable a world where cancer can be detected early, diagnosed accurately, treated in a personalized and targeted way, and ultimately cured. The company’s proprietary RNA and artificial intelligence-based liquid biopsy platform delivers clinical insights into cancer biology to enable the earliest, most accurate diagnosis of cancer. Exai Bio was founded with technology from the UCSF laboratory of Dr. Hani Goodarzi, and consists of veteran leaders in the RNA biology, liquid biopsy, and artificial intelligence/machine learning fields from both academia (UCSF, Stanford, MIT) and industry (Bluestar, CareDx, Evidation, Google, 23andMe, Deep Genomics). Exai Bio is supported by leading life sciences and tech investors including Section 32, Casdin Capital, and Two Sigma Ventures, who have been integral to advancing cancer diagnostics, and artificial intelligence and machine learning technologies. We know that people are our greatest asset and we are rapidly building a rock-star team of talent. Our people are driven by the mission, inspired by the vision of the future, and are committed to living our core values (integrity, openness, teamwork, exploration, and kindness) that connect us to our work and to one another. What We Value Our core values represent what we stand for as a team. This is what we believe in. Everyday, we strive to align our behaviors to these core values in everything we do. Integrity – Our thoughts and actions are true to science and to people. We do the right thing. Openness – We recognize and respect our differences – and embrace learning from them. Teamwork – We are team players who trust and respect each other. Exploration – We are explorers, putting curiosity into action. Kindness – We are kind whenever possible – and we believe it’s always possible.

Life Science Angels (LSA) is the premier angel investing organization in the US, focused on investing exclusively in the life sciences. Since 2005, LSA has invested in 100+ companies in medical technology and biotechnology investment opportunities.

Halteres Associates, LLC, provides strategic and tactical consulting services to bioscience organizations in the areas of diagnostics, therapeutics, medical devices, and life science research. We assist these organizations in the following areas: Technology and product mapping in the context of the competition’s pros and cons Opportunity analyses based on commercial attractiveness and the technical likelihood of success criteria Health economic analyses and reimbursement strategies Clinical study plans including sample banks for diagnostic studies Business modeling and financial analysis